|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 483.15 USD | +0.93% |
|
-0.07% | +6.53% |
| 11:53am | Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570 | MT |
| Aug. 04 | Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Other Pharmaceuticals | +1.03% | -0.07% | +6.53% | +28.80% | +137.93% | 121B |  |  |  |
- Stock Market
- Stocks
- VRTX Stock
- Charts Vertex Pharmaceuticals Incorporated
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
